Hyperglycemia in hospitalized patients is a common and serious finding. Sliding scale insulin is not recommended by many recent guidelines to be used in hospital settings and despite that, it is still the most common strategy in clinical practice in many countries. This review aims to assess the effectiveness and safety of basal-bolus Insulin versus sliding scale Insulin (SSI) in non-critically ill hospitalized patients.
(2022). Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review. Egyptian Society of Diabetes and Lipidology Journal, 2(2), -. doi: 10.21608/esdlj.2022.455800
MLA
. "Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review", Egyptian Society of Diabetes and Lipidology Journal, 2, 2, 2022, -. doi: 10.21608/esdlj.2022.455800
HARVARD
(2022). 'Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review', Egyptian Society of Diabetes and Lipidology Journal, 2(2), pp. -. doi: 10.21608/esdlj.2022.455800
VANCOUVER
Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review. Egyptian Society of Diabetes and Lipidology Journal, 2022; 2(2): -. doi: 10.21608/esdlj.2022.455800
)
